Research
ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells
eLife · By Ali Mobeen ·
The Brief
- A mouse study reports that ITK deficiency protects against autoimmune pulmonary hemorrhage.
- The protective effect is attributed to promoting amphiregulin-producing regulatory T cells.
- Pulmonary hemorrhage is a life-threatening manifestation of systemic autoimmunity that disrupts the alveolar capillary barrier and has high mortality.
Why it matters
The study identifies a molecular checkpoint that may shift destructive inflammation toward immune regulation in a life-threatening autoimmune complication, which is relevant to researchers studying autoimmunity. The evidence comes from mice, so it does not yet show effects in humans.
Who’s affected
- immunologists and researchers studying autoimmune disease
- #itk
- #autoimmunity
- #regulatory t cells
- #pulmonary hemorrhage
- #amphiregulin
Pulmonary hemorrhage (PH) is a life-threatening manifestation of systemic autoimmunity caused by immune-mediated disruption of the alveolar capillary barrier. Despite high mortality, the molecular checkpoints that shift destructive inflammation toward protective immune regulation…